Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Pleural Mesothelioma”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Large-scale testing (Phase 3)Study completedNCT04334759
What this trial is testing

DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

Who this might be right for
MesotheliomaPleural MesotheliomaMalignant Pleural Mesothelioma
PrECOG, LLC. 214
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Not applicableStudy completedNCT05308966
What this trial is testing

Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)

Who this might be right for
Malignant Pleural MesotheliomaUnresectable Malignant Neoplasm
Groupe Francais De Pneumo-Cancerologie 204
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)WithdrawnNCT02661659
What this trial is testing

A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy

Who this might be right for
Malignant Pleural Mesothelioma (MPM)
University of Chicago
Testing effectiveness (Phase 2)UnknownNCT01649024
What this trial is testing

A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese 29
Early research (Phase 1)Study completedNCT00402766
What this trial is testing

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma

Who this might be right for
Mesothelioma
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00053885
What this trial is testing

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT01843374
What this trial is testing

Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma

Who this might be right for
Unresectable Pleural or Peritoneal Malignant Mesothelioma
MedImmune LLC 571
Not applicableEnded earlyNCT00898547
What this trial is testing

Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)Ended earlyNCT00027508
What this trial is testing

Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
PharmaMar
Early research (Phase 1)Ended earlyNCT01445392
What this trial is testing

SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT02357147
What this trial is testing

Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma, Malignant
Morphotek 124
Testing effectiveness (Phase 2)Study completedNCT02611037
What this trial is testing

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

Who this might be right for
Malignant Pleural MesotheliomaMesothelioma
H. Lee Moffitt Cancer Center and Research Institute 34
Large-scale testing (Phase 3)Ended earlyNCT01907100
What this trial is testing

Nintedanib (BIBF 1120) in Mesothelioma

Who this might be right for
Mesothelioma
Boehringer Ingelheim 545
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Ended earlyNCT03233724
What this trial is testing

Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas

Who this might be right for
Carcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Early research (Phase 1)Study completedNCT00019825
What this trial is testing

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Who this might be right for
Esophageal CancerLung CancerMalignant Mesothelioma+1 more
National Cancer Institute (NCI)
Next Page